Application 020647
- Type
- NDA
- Sponsor
- SOMERSET
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELDEPRYL | SELEGILINE HYDROCHLORIDE | CAPSULE;ORAL | 5MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020647-001 | ELDEPRYL | SELEGILINE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1996-05-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N020647-001 | ELDEPRYL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1996-05-15 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020647-001 | ELDEPRYL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1996-05-15 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020647-001 | ELDEPRYL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1996-05-15 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020647-001 | ELDEPRYL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 1996-05-15 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Golden State Medical Supply, Inc. | 040a97e5-efd1-4a2f-b737-2f13e5366d70 | 2025-11-24 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Marlex Pharmaceuticals, Inc. | df88d6bf-0fda-3825-e053-2a95a90a3a75 | 2025-11-21 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Bryant Ranch Prepack | b8eb0a00-adc7-4aaf-987c-fa1b207b2996 | 2025-08-18 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Bryant Ranch Prepack | 4848270a-1179-410c-b4e6-a7e555b3a988 | 2025-07-15 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | A2A Integrated Pharmaceuticals | a59ff47b-4379-44f3-9d2c-f8c6121d1881 | 2025-02-28 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 23c4481f-d150-40c6-addb-b3e454ca914f | 2024-08-07 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Chartwell RX, LLC | 189ac32d-28b4-47c5-9de6-318e502eff3b | 2024-05-08 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | i3 Pharmaceuticals, LLC | c81e983b-455d-2e65-e053-2a95a90a3123 | 2024-03-20 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | A-S Medication Solutions | f286c854-3b8c-44a8-b3b5-c828dbabb207 | 2023-02-06 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Proficient Rx LP | 57b564ef-c89b-4cf6-a11f-f67391d74e7e | 2022-04-01 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| ZELAPAR | SELEGILINE HYDROCHLORIDE | Bausch Health US, LLC | 380d7717-2a79-42f3-a712-efe5e7696ba0 | 2021-06-01 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
| Selegiline Hydrochloride | SELEGILINE HYDROCHLORIDE | Novitium Pharma LLC | e42d99b0-c62e-49d4-b792-1301bb539b92 | 2021-04-01 | Warnings, Adverse reactions | SELEGILINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.